Testing the Engaged Approach to Lung Cancer Screening
The goal of this study is to assess feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) in diverse lung cancer screening (LCS) programs operating in a variety of geographic regions across Colorado and the US.
Checked against the public recordLast updated Dec 22, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Colorado, Denver
- Interventions being studied
- Behavioral: Engaged Approach to Lung Cancer Screening
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: The trial incorporates a multilevel assessment and enrollment involves inclusion criteria at two levels: (1) LCS Program and (2) LCS Program Staff member. Program inclusion criteria (n = up to 8 sites): * Must conduct at least 50 low-dose computed tomography (LDCT) scans per year (baseline + follow-up) * Must be able to identify a primary contact person for LCS program operations (e.g., program coordinator, program navigator, program manager, etc.) Staff member inclusion criteria (n \~ 5 at each site/\~40 participants total): * Identified staff member of the LCS program site * \>18 years of age * Must be able to complete study surveys and interviews in English * Willing to provide informed consent Exclusion Criteria: * none
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Colorado HospitalDenver, Colorado
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 22, 2025. Always confirm current availability with the study team.